Product Name:1-[6-(1H-imidazol-1-yl)pyrimidin-4-yl]-N-(4H-1,2,4-triazol-4-yl)piperidine-4-carboxamide

IUPAC Name:1-[6-(1H-imidazol-1-yl)pyrimidin-4-yl]-N-(4H-1,2,4-triazol-4-yl)piperidine-4-carboxamide

CAS:1351651-56-3
Molecular Formula:C15H17N9O
Purity:95%+
Catalog Number:CM616649
Molecular Weight:339.36

Packing Unit Available Stock Price($) Quantity

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:1351651-56-3
Molecular Formula:C15H17N9O
Melting Point:-
Smiles Code:O=C(NN1C=NN=C1)C1CCN(CC1)C1=CC(=NC=N1)N1C=CN=C1
Density:
Catalog Number:CM616649
Molecular Weight:339.36
Boiling Point:
MDL No:
Storage:

Category Infos

Piperidines
Piperidine is an azacycloalkane that is cyclohexane in which one of the carbons is replaced by a nitrogen. Although piperidine is a common organic compound, it is an immensely important class of compounds medicinally: the piperidine ring is the most common heterocyclic subunit among FDA approved drugs.
Piperidine,Piperidine Price
if you want to know the latest news about piperidine and piperidine price, please come to our website and get a quote for free.
Pyrimidines
Pyrimidine, also known as 1,3-diazobenzene, is a heterocyclic compound with the chemical formula C4H4N2. Pyrimidine is formed by substituting 2 nitrogen atoms for 2 carbons in the meta-position of benzene. It is a diazine and retains its aromaticity. Derivatives of pyrimidine widely exist in organic macromolecular nucleic acids, and many drugs also contain pyrimidine rings. In nucleic acids, three nucleobases are pyrimidine derivatives: cytosine, thymine and uracil. There are a variety of pyrimidine-containing drugs on the market, most of which are kinase inhibitors.
Triazoles
Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.

Related Products